Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02319525 · ClinicalTrials.gov registry record · NA
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 301
- Enrollment target
NCT02319525 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 301 participants.
The verdict
NCT02319525, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 301 participants
- Enrollment target
Study Summary
The study will compare the efficacy of the usual education materials to individualized computerized decision guide on decision conflict of patients with lupus nephritis making treatment decisions regarding immunosuppressive therapies.
Interventions
- OTHER Computerized patient decision-aid
- OTHER Usual care (lupus pamphlet)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02319525
The ClinicalTrials.gov registry entry for NCT02319525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Computerized patient decision-aid is the first listed.
NCT02319525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02319525 about?
NCT02319525 is a clinical study titled "Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus". The study will compare the efficacy of the usual education materials to individualized computerized decision guide on decision conflict of patients with lupus nephritis making treatment decisions regarding immunosuppressive therapies.
What is the current status of trial NCT02319525?
This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2014-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02319525?
The interventions under investigation include: Computerized patient decision-aid (OTHER), Usual care (lupus pamphlet) (OTHER).
Who is sponsoring clinical trial NCT02319525?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.